Assignee
AGOURON PHARMA
US162 patents
Top patents by PatentIndex Score
US5484926AJan 16, 1996
HIV protease inhibitors
AGOURON PHARMA158 citations99
US6884890B2Apr 26, 2005
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA178 citations98
US6534524B1Mar 18, 2003
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA277 citations98
US7008953B2Mar 7, 2006
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
AGOURON PHARMA97 citations97
US6919461B2Jul 19, 2005
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
AGOURON PHARMA103 citations97
US6555539B2Apr 29, 2003
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
AGOURON PHARMA171 citations97
US5753653AMay 19, 1998
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
AGOURON PHARMA151 citations97
US7232912B2Jun 19, 2007
Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
AGOURON PHARMA94 citations96
US7112603B2Sep 26, 2006
Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
AGOURON PHARMA32 citations96
US5827891AOct 27, 1998
HIV protease inhibtors
AGOURON PHARMA36 citations96
US6635641B2Oct 21, 2003
Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA83 citations95
US6008243ADec 28, 1999
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
AGOURON PHARMA70 citations95
US5985900ANov 16, 1999
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
AGOURON PHARMA63 citations95
US5707992AJan 13, 1998
Antiproliferative quinazolines
AGOURON PHARMA44 citations95
US6495541B1Dec 17, 2002
Tricyclic inhibitors of poly(ADP-ribose) polymerases
AGOURON PHARMA76 citations94
US5430148AJul 4, 1995
Antiproliferative quinazolines
AGOURON PHARMA75 citations94
US7141587B2Nov 28, 2006
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
AGOURON PHARMA17 citations92
US6891044B2May 10, 2005
Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use
AGOURON PHARMA20 citations92
US6462069B2Oct 8, 2002
Compounds, pharmaceutical compositions, and methods for inhibiting protein kinases
AGOURON PHARMA21 citations92
US5824688AOct 20, 1998
HIV protease inhibitors
AGOURON PHARMA20 citations92
US5608082AMar 4, 1997
Compounds useful as antiproliferative agents and GARFT inhibitors
AGOURON PHARMA27 citations92
US5527829AJun 18, 1996
HIV protease inhibitors
AGOURON PHARMA37 citations92
US7858643B2Dec 28, 2010
Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
AGOURON PHARMA28 citations91
US7452537B2Nov 18, 2008
P-cadherin antibodies
AGOURON PHARMA40 citations91
US7045646B2May 16, 2006
Process to produce enantiomerically enriched alcohols and amines
AGOURON PHARMA21 citations91
US6569878B1May 27, 2003
Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
AGOURON PHARMA25 citations91
US6218426B1Apr 17, 2001
Non-peptide GnRH agents
AGOURON PHARMA29 citations91
US6153757ANov 28, 2000
Metalloproteinase inhibitors and intermediates useful for their preparation
AGOURON PHARMA29 citations91
US5962487AOct 5, 1999
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA25 citations91
US5856530AJan 5, 1999
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA32 citations91
US5705647AJan 6, 1998
Intermediates for making HIV-protease inhibitors
AGOURON PHARMA24 citations91
US7462713B2Dec 9, 2008
Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
AGOURON PHARMA18 citations90
US7429578B2Sep 30, 2008
Tricyclic inhibitors of poly(ADP-ribose) polymerases
AGOURON PHARMA16 citations90
US7132533B2Nov 7, 2006
Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
AGOURON PHARMA21 citations90
US6967198B2Nov 22, 2005
Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
AGOURON PHARMA17 citations90
US5885996AMar 23, 1999
Antiproliferative quinazolines
AGOURON PHARMA36 citations90
US5314685AMay 24, 1994
Anhydrous formulations for administering lipophilic agents
AGOURON PHARMA53 citations90
US6548494B1Apr 15, 2003
Tricyclic inhibitors of poly(ADP-ribose) polymerases
AGOURON PHARMA48 citations89
US6514997B2Feb 4, 2003
Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
AGOURON PHARMA22 citations89
US6469021B1Oct 22, 2002
Non-peptide antagonists of GLP-1 receptor and methods of use
AGOURON PHARMA23 citations89
US6620828B2Sep 16, 2003
Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
AGOURON PHARMA45 citations88
US6316603B1Nov 13, 2001
Modifications of the VEGF receptor-2 protein and methods of use
AGOURON PHARMA15 citations88
US5863950AJan 26, 1999
HIV protease inhibitors
AGOURON PHARMA44 citations88
US5714518AFeb 3, 1998
HIV protease inhibitors and methods of making the same
AGOURON PHARMA42 citations88
US7101878B1Sep 5, 2006
Non-peptide GNRH agents, methods and intermediates for their preparation
AGOURON PHARMA41 citations87
US6995171B2Feb 7, 2006
Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents
AGOURON PHARMA24 citations86
US6280940B1Aug 28, 2001
Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
AGOURON PHARMA19 citations86
US7232910B2Jun 19, 2007
Methods of preparing indazole compounds
AGOURON PHARMA27 citations85
US6964957B2Nov 15, 2005
Fused pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity
AGOURON PHARMA30 citations84
US7465842B2Dec 16, 2008
Enantioselective biotransformation for preparation of protein tyrosine kinase inhibitor intermediates
AGOURON PHARMA15 citations83
Showing the top 50 of 162 patents by PatentIndex Score.